跳至主要内容
临床试验/EUCTR2008-001009-41-GB
EUCTR2008-001009-41-GB进行中(未招募)1 期

mycophenylate mofetil and tacrolimus vs tacrolimus alone for the treatment of nephrotic syndrome secondary to idiopathic membranous glomerulonephritis - MTAC

Imperial College Healthcare NHS trust0 个研究点目标入组 40 人开始时间: 2008年5月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Idiopathic membranous glomerulonephritis on renal biopsy
  • Heavy proteinuria- protein/creatinine ratio (PCR) >100 units with hypoalbuminaemia, or PCR >300 units with normal serum albumin -despite 3 months treatment with maximum tolerated doses of ACE inhibitors and angiotensin 2 antagonists.
  • Male or female patients age 18-80 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Hepatits B, hepatitis C or HIV positive
  • Untreated infection
  • Females who are pregnant, or breastfeeding, or at risk of pregnancy and not using adequate contraception.
  • Any condition judged by the investigator that would cause the study to be detrimental to the patient.

研究者

相似试验

mycophenylate mofetil and tacrolimus vs tacrolimus... | 临床试验